SG&A Expenses: A Tale of Two Companies

Walgreens Boots Alliance vs. Amicus Therapeutics

In the ever-evolving landscape of corporate finance, understanding the trends in Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Walgreens Boots Alliance, Inc. has consistently reported SG&A expenses that dwarf those of Amicus Therapeutics, Inc. In 2023, Walgreens' expenses were approximately 92 times higher than Amicus's, highlighting the scale of operations and market reach of the retail giant.

From 2014 to 2023, Amicus Therapeutics saw a staggering 1,230% increase in SG&A expenses, reflecting its aggressive growth strategy. In contrast, Walgreens Boots Alliance experienced a more modest 44% rise, indicative of its mature market position. Notably, 2024 data for Amicus is missing, suggesting potential reporting delays or strategic shifts.

These insights underscore the diverse financial strategies employed by companies in different stages of their lifecycle, offering a fascinating glimpse into corporate financial management.